Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.80 USD
+0.02 (0.72%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $2.80 0.00 (0.00%) 4:48 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
GBIO 2.80 +0.02(0.72%)
Will GBIO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GBIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GBIO
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
GBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio
Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect?
Other News for GBIO
Wall Street Analysts Are Bullish on Top Healthcare Picks
Analysts Are Bullish on These Healthcare Stocks: Generation Bio (GBIO), Poseida Therapeutics (PSTX)
Commit To Purchase Generation Bio Co At $2.50, Earn 28.9% Annualized Using Options
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
Third Harmonic Bio appoints McDonough to board of directors